The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design.
about
Mammalian protein glycosylation--structure versus function.Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.Hormones as doping in sports.Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin.Detection of peptidic erythropoiesis-stimulating agents in sport.Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions.Immunomagnetic beads-based isolation of erythropoietins from urine and blood for sports anti-doping control.Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.
P2860
Q33358345-C559480A-C754-4744-B77A-C97FDA954F75Q38029405-CADCFD3A-6F68-438E-AE85-7A73F3B5EDB5Q38044615-A1392009-6E6C-4F20-8588-B0A38F6C3489Q38083095-0235B1F1-B68A-46B4-B5B3-08E1F36BBC71Q38200014-C26CCA2A-D469-4FE2-BB98-AA2C6B0C38B0Q39100829-4F8E5D03-F2BA-4450-A7D8-08B490FE8255Q47673316-FBF3C39B-6538-401A-AB21-506C4496AFBDQ50951247-03368CEE-C99B-4FF6-9564-D5F553C03D42
P2860
The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The overlooked difference betw ...... nd pharmaceutical drug design.
@en
The overlooked difference betw ...... nd pharmaceutical drug design.
@nl
type
label
The overlooked difference betw ...... nd pharmaceutical drug design.
@en
The overlooked difference betw ...... nd pharmaceutical drug design.
@nl
prefLabel
The overlooked difference betw ...... nd pharmaceutical drug design.
@en
The overlooked difference betw ...... nd pharmaceutical drug design.
@nl
P2860
P356
P1476
The overlooked difference betw ...... nd pharmaceutical drug design.
@en
P2093
Christian Reichel
P2860
P304
P356
10.1002/DTA.388
P577
2011-11-01T00:00:00Z